Month: <span>October 2017</span>

Home / 2017 / October
Post

Anti-cancer drugs could prevent the hardening of blood vessels that cause heart attack and stroke

Anti-cancer drugs could prevent the build-up of fatty plaques in blood vessels which cause heart attack and stroke, a new study by the University of Sheffield has shown. The new research, funded by the British Heart Foundation, suggests drugs which are already in clinical trials for the treatment of cancers could be repurposed to prevent atherosclerosis –...

Post

Diabetes researchers discover potential new insulin sensitizers

Potential drug lowered blood sugar without triggering fat storage in mice New York, NY (October 24, 2017)–A root cause of type 2 diabetes is a condition known as insulin resistance, in which cells stop responding to commands from the hormone that regulates glucose (sugar) storage. Restoring insulin sensitivity can be an effective strategy for preventing...

Post

A non-invasive computational imaging approach may predict response to immunotherapy

A computational imaging-based signature of immune-cell infiltration in and around a tumor could predict patients’ responses to treatment with anti-PD1/PDL1 immunotherapies, according to data from a study presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 26-30. “Immunotherapy, a recent modality of treatment in oncology, has profoundly changed the management...

Post

Researchers reveal the role of a DNA repair mechanism

Fernando Gómez Herreros and his research team.   Researchers from the University of Seville, in collaboration with the Genome Damage and Stability Centre of the University of Sussex in the United Kingdom, have recently published a study in the review Nature Communications, in which they make an important step forward in understanding more exactly what the...

Post

RNA Editing Possible with CRISPR-Cas13

Scientists extend the capabilities of the CRISPR-Cas system to include precise manipulations of RNA sequences in human cells. WIKIMEDIA, NICOLLE RAGER, NATIONAL SCIENCE FOUNDATION  Fusing an RNA-editing enzyme to an RNA-targeting Cas protein has enabled researchers to edit specific nucleotides within RNA molecules in human cells. The approach, called RNA Editing for Programmable A-to-I replacement (REPAIR),...

Post

RNA Editing Possible with CRISPR-Cas13

Scientists extend the capabilities of the CRISPR-Cas system to include precise manipulations of RNA sequences in human cells. Fusing an RNA-editing enzyme to an RNA-targeting Cas protein has enabled researchers to edit specific nucleotides within RNA molecules in human cells. The approach, called RNA Editing for Programmable A-to-I replacement (REPAIR), is described today (October 25)...

Post

Immunotherapy with peptides

Abstract Specific allergen immunotherapy is clinically effective and disease modifying. It has a duration of effect that exceeds the treatment period and prevents both the progression of allergic rhinitis to asthma and the acquisition of new allergic sensitizations. However, immunotherapy is associated with a high frequency of adverse events related to the allergenicity of vaccines....

Post

Details uncovered in development of immune cell implicated in cancer, autoimmune diseases

While the immune system is critical for fighting off invading micro-organisms, sometimes it can turn against the body and attack healthy tissues or be involved in cancer cell growth. A study by University of North Carolina Lineberger Comprehensive Cancer Center researchers provides new details about the development of a particular immune cell that can play...